Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-β-lactamase BlaB.

Authors:
Address: Instituto de Biologia Molecular y Celular de Rosario, CONICET, Facultad de Ciencias Bioquimicas y Farmaceuticas, Universidad Nacional de Rosario, Rosario, Argentina.
Journal:


Publication:

abstract

Elizabethkingia meningoseptica, a Gram-negative rod widely distributed in the environment, is resistant to most β-lactam antibiotics. Three bla genes have been identified in E. meningoseptica, coding for the extended-spectrum serine-β-lactamase CME (class D) and two unrelated wide-spectrum metallo-β-lactamases, BlaB (subclass B1) and GOB (subclass B3). E. meningoseptica is singular in being the only reported microorganism possessing two chromosomally encoded MBL genes. Real-time PCR and biochemical analysis demonstrate that the three bla genes are actively expressed in vivo as functional β-lactamases. However, while CME elicits cephalosporin resistance, BlaB is the only β-lactamase responsible for E. meningoseptica resistance to imipenem, as GOB activity is masked by higher cellular levels of BlaB. On the other hand, we demonstrate that bla(BlaB) expression is higher in the stationary phase or under conditions that mimic the nutrient-limiting cerebrospinal fluid colonized by E. meningoseptica in human meningitis.



Related Articles
Genetic diversity of chromosomal metallo-beta-lactamase genes in clinical isolates of Elizabethkingia meningoseptica from Korea.
J Microbiol. 2010
Genetic diversity of chromosomal metallo-beta-lactamase genes in clinical isolates of Elizabethkingia meningoseptica from Korea.
Yum JH, Lee EY, Hur SH, Jeong SH, Lee H, Yong D, Chong Y, Lee EW, Nordmann P, Lee K. J Microbiol. 2010 Jun; 48(3):358-64. Epub 2010 Jun 23.
Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum.
Antimicrob Agents Chemother. 2...
Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum.
Bellais S, Aubert D, Naas T, Nordmann P. Antimicrob Agents Chemother. 2000 Jul; 44(7):1878-86.
Heterogeneity of metallo-beta-lactamases in clinical isolates of Chryseobacterium meningosepticum from Hangzhou, China.
J Antimicrob Chemother. 2006
Heterogeneity of metallo-beta-lactamases in clinical isolates of Chryseobacterium meningosepticum from Hangzhou, China.
Chen GX, Zhang R, Zhou HW. J Antimicrob Chemother. 2006 Apr; 57(4):750-2. Epub 2006 Feb 14.
Review Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
Int J Med Microbiol. 2010
Review Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
Pfeifer Y, Cullik A, Witte W. Int J Med Microbiol. 2010 Aug; 300(6):371-9. Epub 2010 May 27.
Review Beta-lactamase inhibitors: the story so far.
Curr Med Chem. 2009
Review Beta-lactamase inhibitors: the story so far.
Pérez-Llarena FJ, Bou G. Curr Med Chem. 2009; 16(28):3740-65.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.